Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the operating margin high or low?
The operating margin of -164525.50% is 1931% below its 5-year average of -8099.63%, near the low end of its 5-year range (-582075.02%–2308149.17%).
2291.16% below its 12-month average of -6880.56%.
Reported quarterly operating margin; no daily interpolation. Q2 FY2026 (2026-06-30): 0.00%.
OPERATING MARGIN
-164525.50%
OPERATING MARGIN AVG TTM
-6880.56%
OPERATING MARGIN AVG 3Y
-9980.26%
OPERATING MARGIN AVG 5Y
-8099.63%
OPERATING MARGIN AVG 10Y
0.00%
OPERATING MARGIN AVG 15Y
N/A
OPERATING MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
-2291.16%
CURRENT VS 3Y AVG
-1548.51%
CURRENT VS 5Y AVG
-1931.27%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
0.00%
median of 745 covered companies
CURRENT VS SECTOR MEDIAN
N/A
vs the sector median at left
InflaRx N.V.
Market Cap
$238.61M
Operating Margin
-164525.50%
TTM Avg
-6880.56%
3Y Avg
-9980.26%
5Y Avg
-8099.63%
Market Cap
$238.23M
Operating Margin
25.05%
TTM Avg
37.75%
3Y Avg
43.45%
5Y Avg
51.35%
Market Cap
$239.90M
Operating Margin
9.95%
TTM Avg
-10.78%
3Y Avg
-18.24%
5Y Avg
-54.36%
Market Cap
$240.02M
Operating Margin
-1488.31%
TTM Avg
-4815.32%
3Y Avg
-6115.40%
5Y Avg
-4078.06%
Market Cap
$236.81M
Operating Margin
0.56%
TTM Avg
-0.74%
3Y Avg
-7.55%
5Y Avg
-6.74%
Market Cap
$241.69M
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$233.59M
Operating Margin
-48.72%
TTM Avg
-61.63%
3Y Avg
-124.59%
5Y Avg
-150.09%
Market Cap
$242.34M
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$234.18M
Operating Margin
-1026.28%
TTM Avg
-515.73%
3Y Avg
-257.87%
5Y Avg
-257.87%
| NAME | MARKET CAP | OPERATING MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| InflaRx N.V. (IFRX) | $238.61M | -164525.50% | -6880.56% | -9980.26% | -8099.63% |
| SIGA Technologies, Inc. (SIGA)vs › | $238.23M | 25.05% | 37.75% | 43.45% | 51.35% |
| Akebia Therapeutics, Inc. (AKBA)vs › | $239.90M | 9.95% | -10.78% | -18.24% | -54.36% |
| CAMP4 Therapeutics Corporation (CAMP)vs › | $240.02M | -1488.31% | -4815.32% | -6115.40% | -4078.06% |
| High Tide Inc. (HITI)vs › | $236.81M | 0.56% | -0.74% | -7.55% | -6.74% |
| Galectin Therapeutics Inc. (GALT)vs › | $241.69M | 0.00% | 0.00% | 0.00% | 0.00% |
| MacroGenics, Inc. (MGNX)vs › | $233.59M | -48.72% | -61.63% | -124.59% | -150.09% |
| Greenwich LifeSciences, Inc. (GLSI)vs › | $242.34M | 0.00% | 0.00% | 0.00% | 0.00% |
| BioAge Labs Inc. (BIOA)vs › | $234.18M | -1026.28% | -515.73% | -257.87% | -257.87% |
| Lifecore Biomedical, Inc. (LFCR)vs › | $243.62M | N/A | -7.18% | -10.59% | -10.29% |
Gross Margin
-24677.9%
Operating Margin
-164525.5%
Operating Margin = Operating Income / Revenue
Operating margin is the percentage of revenue remaining after operating expenses, reflecting operating efficiency.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | OPERATING MARGIN |
|---|---|
| 2026-06-30 | 0.00% |
| 2026-03-31 | 0.00% |
| 2025-12-31 | 37891.13% |
| 2025-09-30 | -39769.22% |
| 2025-06-30 | -32524.74% |
| 2025-03-31 | 0.00% |
| 2024-12-31 | 2308149.17% |
| 2024-09-30 | -12405.24% |
| 2024-06-30 | -242200.14% |
| 2024-03-31 | -34655.19% |
| 2023-12-31 | -582075.02% |
| 2023-09-30 | -18339.32% |
| 2023-06-30 | 0.00% |
| 2023-03-31 | 0.00% |
| 2022-12-31 | 0.00% |
| 2022-09-30 | 0.00% |
| 2022-06-30 | 0.00% |
| 2022-03-31 | 0.00% |
| 2021-12-31 | 0.00% |
| 2021-09-30 | 0.00% |
| 2021-06-30 | 0.00% |
| 2021-03-31 | 0.00% |
| 2020-12-31 | 0.00% |
| 2020-09-30 | 0.00% |
| 2020-06-30 | 0.00% |
| 2020-03-31 | 0.00% |
| 2019-12-31 | 0.00% |
| 2019-09-30 | 0.00% |
| 2019-06-30 | 0.00% |
| 2019-03-31 | 0.00% |
| 2018-12-31 | 0.00% |
| 2018-09-30 | 0.00% |
| 2018-06-30 | 0.00% |
| 2018-03-31 | 0.00% |
| 2017-12-31 | 0.00% |
| 2017-09-30 | 0.00% |
| 2017-06-30 | 0.00% |
| 2017-03-31 | 0.00% |
| 2016-12-31 | 0.00% |
| 2016-09-30 | 0.00% |
| 2016-06-30 | 0.00% |
| 2016-03-31 | 0.00% |
